• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Insights from Kayentis clients: why you should choose Kayentis as your eCOA & DCT provider

Project management
9 March 2023

Responsiveness, reliability, professionalism, friendliness… discover why 95.6% of Kayentis clients recommend Kayentis in 2023!

Challenge your eCOA & DCT provider: choose Kayentis for your next clinical trial!

Download the infographic
Follow us on social media
Subscribe to our newsletter
You may also like

Strategies to promote BYOD adoption by clinical study sites

How Kayentis reduces the CO2 emissions of your eCOA projects...

Empowering patients through data: a collaborative vision of clinical data...

If Patients Want A Better Quality Of Life, Why Isn’t...

Strategies to overcome clinical trials complexities

Kayentis 2024 Gender Equality Index

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
Meet us at the following events

OCT East Coast 2025

MAY 20-21 2025 • King of Prussia, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

PCMG 2025

JUNE 10-12 2025 • Malaga, Spain
PCMG Annual Assembly 2025

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA